The Nasdaq granted Onconova Therapeutics Inc. time to regain compliance with the exchange's minimum stockholders' equity requirement of $2.5 million.
The Newtown, Pa.-based biotechnology company developing treatments for cancer has until April 13 to regain compliance.
